Inflammatory factors such as IL-18 may stimulate Th2 responses and angiogenesis, leading to enhanced tumor migration and invasion, and IL-1β can attract monocytes in the TME and operate as a master cytokine in cancer growth, as well as dampen T cell responses in the TME [41–44]. This evidence concerns the gene IL1B and neoplasm.